Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | 0.00% | +9.09% | +4.35% |
06-05 | Arovella Therapeutics Completes Process Development for ALA-101 Manufacturing; Shares Jump 9% | MT |
03-26 | Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.35% | 80.28M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- ALA Stock
- News Arovella Therapeutics Limited
- Arovella Therapeutics Partner STADA Begins Commercial Launch of Insomnia Drug in Australia